Leflunomide Sandoz

Leflunomide, the active ingredient in Leflunomide Sandoz, is a disease-modifying antirheumatic drug (DMARD) presented as tablets for oral use. It is indicated for the treatment of rheumatoid arthritis and psoriatic arthritis in adult patients, helping to reduce joint inflammation and slow disease progression.

GNH USA supplies Leflunomide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, ensuring timely delivery and regulatory compliance.

Leflunomide is a disease-modifying antirheumatic drug used to manage autoimmune joint disorders.

- Rheumatoid arthritis: reduces joint pain, swelling and slows structural damage. - Psoriatic arthritis: improves skin and joint symptoms and limits disease progression.

Leflunomide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Diarrhea: loose stools that may be intermittent. - Nausea: feeling of stomach upset, often mild. - Alopecia: thinning or loss of hair. - Rash: skin irritation or redness. - Elevated liver enzymes: mild increase in ALT/AST. - Hypertension: rise in blood pressure readings.

Serious or Rare Side Effects: - Severe liver injury: jaundice, fatigue, dark urine. - Bone marrow suppression: anemia, leukopenia, thrombocytopenia. - Pulmonary toxicity: cough, shortness of breath. - Stevens‑Johnson syndrome: severe skin blistering. - Serious infections: opportunistic or bacterial infections. - Teratogenicity: risk of fetal harm if exposure occurs during pregnancy.

Before prescribing Leflunomide, clinicians should assess several safety factors.

- Pregnancy: contraindicated (Category X); avoid use in women of childbearing potential. - Liver function: obtain baseline tests and monitor periodically. - Infection risk: evaluate for active infections before initiation. - Blood pressure: monitor regularly, especially in hypertensive patients. - Vaccination: avoid live vaccines during treatment. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Leflunomide can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, monitor INR closely. - Methotrexate: additive hepatotoxicity, consider dose adjustment. - Live vaccines: heightened risk of infection, avoid concurrent use.

Moderate Interactions (Monitor Closely): - Azathioprine: potential for enhanced myelosuppression. - Cyclosporine: increased Leflunomide exposure, monitor levels. - Statins: higher risk of myopathy, observe muscle symptoms.